Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.

Literature DB >> 3729326

Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.

Abstract

Tests with 52 strains of Staphylococcus aureus compared ceforanide and cefonicid. Addition of 50% human serum to the test system reduced the bacteriostatic and bactericidal activities of cefonicid, but ceforanide was not affected as greatly.

Entities: Chemical Species

Mesh：

Substances：

Year: 1986 PMID： 3729326 PMCID： PMC180380 DOI： 10.1128/AAC.29.1.147

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

12 in total

1. In-vitro methods for determining minimal lethal concentrations of antimicrobial agents.

Authors: A L Barry; R A Lasner
Journal: Am J Clin Pathol Date: 1979-01 Impact factor: 2.493

2. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.

Authors: R N Jones; C Thornsberry; A L Barry; P C Fuchs; T L Gavin; E H Gerlach
Journal: J Antibiot (Tokyo) Date: 1977-07 Impact factor: 2.649

3. Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.

Authors: R D Smyth; M Pfeffer; A Glick; D R Van Harken; G H Hottendorf
Journal: Antimicrob Agents Chemother Date: 1979-11 Impact factor: 5.191

4. Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.

Authors: D F Sahm; C N Baker; R N Jones; C Thornsberry
Journal: J Clin Microbiol Date: 1984-09 Impact factor: 5.948

5. Effect of hydrogen ion and protein concentrations on the activity of beta-lactam antibiotics.

Authors: R Platt; B Rosner
Journal: Rev Infect Dis Date: 1984 Nov-Dec

6. SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.

Authors: P Actor; J V Uri; I Zajac; J R Guarini; L Phillips; D H Pitkin; D A Berges; G L Dunn; J R Hoover; J A Weisbach
Journal: Antimicrob Agents Chemother Date: 1978-05 Impact factor: 5.191

7. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers.

Authors: R L Greenman; S M Arcey; D A Gutterman; R M Zweig
Journal: Antimicrob Agents Chemother Date: 1984-01 Impact factor: 5.191

8. Tissue penetration and half-life of cefonicid.

Authors: C H Nightingale; R Quintiliani; M N Dudley; P Gough; M Hickingbotham; N S Jordan; D Rose; M Toscani
Journal: Rev Infect Dis Date: 1984 Nov-Dec

9. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.

Authors: H F Chambers; J Mills; T A Drake; M A Sande
Journal: Rev Infect Dis Date: 1984 Nov-Dec

10. Comparison of cefonicid and cefazolin for treatment of soft-tissue infections.

Authors: G Slutkin; J Marzouk; L Dall; J Mills
Journal: Rev Infect Dis Date: 1984 Nov-Dec

5 in total

1. Effects of supraphysiologic temperature and broth dilution on serum protein binding.

Authors: R L White; M B Kays; T A Armstrong; L V Friedrich
Journal: Antimicrob Agents Chemother Date: 1990-06 Impact factor: 5.191

2. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.

Authors: R N Jones; A L Barry
Journal: Antimicrob Agents Chemother Date: 1987-05 Impact factor: 5.191